Product Program year 2025 Source: CMS Open Payments

Datroway

Drug Oncology

NDC 65597-801-01

Open in the dashboard

General payments

$1,677,009

9,517 payments

Research payments

$10,488,777

2,026 payments

Through program year 2025, $1,677,009 in general payments and $10,488,777 in research payments were reported against Datroway (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $1,677,009 9,517
2025 Research $10,488,777 2,026

Breakdown

Who paid General payments · program year 2025
  1. Daiichi Sankyo Inc. $1,668,746 9,513 payments
  2. Daiichi Sankyo Company LTD $8,263 4 payments
Top recipients General payments · program year 2025
  1. Amit Patel Hematology & Oncology · Jersey City, NJ $47,162 3% · 33 payments
  2. Toby Maher Pulmonary Disease · Los Angeles, CA $46,526 3% · 2 payments
  3. Jonathan Chung Diagnostic Radiology · San Diego, CA $45,845 3% · 13 payments
  4. Charles Powell Pulmonary Disease · New York, NY $45,563 3% · 5 payments
  5. Hatim Husain Internal Medicine · San Diego, CA $41,230 2% · 25 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $635,919 38% · 1,619 practitioners
  2. Medical Oncology Internal Medicine $420,456 25% · 494 practitioners
  3. Pulmonary Disease Internal Medicine $134,048 8% · 16 practitioners
  4. Nurse Practitioner $91,574 5% · 546 practitioners
  5. Diagnostic Radiology Radiology $76,012 5% · 12 practitioners

The top 5 of 87 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $318,666 19% · 533 recipients
  2. Florida $147,309 9% · 792 recipients
  3. New York $137,301 8% · 155 recipients
  4. Texas $124,713 7% · 311 recipients
  5. Pennsylvania $80,367 5% · 198 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

9,517 general · 2,026 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record